NDC Pharmacologic Class N0000190480 Interleukin-6 Receptor Antagonist [EPC]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0024-5908 | Kevzara | Sarilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5910 | Kevzara | Sarilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5920 | Kevzara | Sarilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5922 | Kevzara | Sarilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
50242-135 | Actemra | Tocilizumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | Human Prescription Drug |
50242-136 | Actemra | Tocilizumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | Human Prescription Drug |
50242-137 | Actemra | Tocilizumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | Human Prescription Drug |
50242-138 | Actemra | Tocilizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | Human Prescription Drug |
50242-143 | Actemra Actpen | Tocilizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | Human Prescription Drug |
There are 9 NDC products with the pharmacologic class Interleukin-6 Receptor Antagonist [EPC].